Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Long-term outcomes for primary glomerulonephritis: New Zealand Glomerulonephritis Study.

Chembo CL, Marshall MR, Williams LC, Walker RJ, Lynn KL, Irvine J, Pilmore HL.

Nephrology (Carlton). 2015 Dec;20(12):899-907. doi: 10.1111/nep.12538.

PMID:
26096749
2.

Survival on home dialysis in New Zealand.

Marshall MR, Walker RC, Polkinghorne KR, Lynn KL.

PLoS One. 2014 May 7;9(5):e96847. doi: 10.1371/journal.pone.0096847. eCollection 2014.

3.

Myocardial metastasis of cutaneous squamous cell carcinoma in a renal transplant recipient.

Mackenzie KA, Simcock JW, Lainchbury JG, Currie MJ, Lynn KL.

Transplant Proc. 2009 Dec;41(10):4414-5. doi: 10.1016/j.transproceed.2009.09.056.

PMID:
20005411
4.

First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients.

Mackenzie KA, Wells JE, Lynn KL, Simcock JW, Robinson BA, Roake JA, Currie MJ.

Nephrol Dial Transplant. 2010 Jan;25(1):300-6. doi: 10.1093/ndt/gfp482. Epub 2009 Sep 25.

PMID:
19783601
5.

Future of home haemodialysis in Australia and New Zealand.

Lynn KL, Buttimore AL.

Nephrology (Carlton). 2005 Jun;10(3):231-3. Review.

PMID:
15958034
6.

A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis.

Winn MP, Conlon PJ, Lynn KL, Farrington MK, Creazzo T, Hawkins AF, Daskalakis N, Kwan SY, Ebersviller S, Burchette JL, Pericak-Vance MA, Howell DN, Vance JM, Rosenberg PB.

Science. 2005 Jun 17;308(5729):1801-4. Epub 2005 May 5.

7.

Hypertension and survival in hemodialysis patients.

Lynn KL.

Semin Dial. 2004 Jul-Aug;17(4):270-4. Review.

PMID:
15250916
8.

Diagnosis of aspergillus peritonitis in a renal dialysis patient by PCR and galactomannan detection.

Scotter JM, Stevens JM, Chambers ST, Lynn KL, Patton WN.

J Clin Pathol. 2004 Jun;57(6):662-4.

9.

Long-term survival of arteriovenous fistulas in home hemodialysis patients.

Lynn KL, Buttimore AL, Wells JE, Inkster JA, Roake JA, Morton JB.

Kidney Int. 2004 May;65(5):1890-6.

10.

Effects of long and short hemodialysis on endothelial function: a short-term study.

McGregor DO, Buttimore AL, Lynn KL, Yandle T, Nicholls MG.

Kidney Int. 2003 Feb;63(2):709-15.

11.

Hypertension as a determinant of survival for patients treated with home dialysis.

Lynn KL, McGregor DO, Moesbergen T, Buttimore AL, Inkster JA, Wells JE.

Kidney Int. 2002 Dec;62(6):2281-7.

12.

Successful treatment of CAPD peritonitis caused by rhodotorula mucilaginosa.

de Zoysa JR, Searle M, Lynn KL, Robson RA.

Perit Dial Int. 2001 Nov-Dec;21(6):627-8. No abstract available.

PMID:
11783780
13.

Acute renal failure in a patient with paroxysmal nocturnal hemoglobinuria.

Jose MD, Lynn KL.

Clin Nephrol. 2001 Aug;56(2):172-4.

PMID:
11522096
14.

Cost-benefit analysis and prediction of 24-hour proteinuria from the spot urine protein-creatinine ratio.

Chitalia VC, Kothari J, Wells EJ, Livesey JH, Robson RA, Searle M, Lynn KL.

Clin Nephrol. 2001 Jun;55(6):436-47.

PMID:
11434354
15.

Autonomic dysfunction and ambulatory blood pressure in renal transplant recipients.

McGregor DO, Olsson C, Lynn KL.

Transplantation. 2001 May 15;71(9):1277-81.

PMID:
11397962
16.

Hypotensive and natriuretic actions of adrenomedullin in subjects with chronic renal impairment.

McGregor DO, Troughton RW, Frampton C, Lynn KL, Yandle T, Richards AM, Nicholls MG.

Hypertension. 2001 May;37(5):1279-84.

PMID:
11358941
17.

A Comparative Study of Blood Pressure Control with Short In-Center versus Long Home Hemodialysis.

McGregor DO, Buttimore AL, Lynn KL, Nicholls MG, Jardine DL.

Blood Purif. 2001;19(3):293-300.

PMID:
11244189
18.
19.

Home hemodialysis: excellent survival at less cost, but still underutilized.

McGregor DO, Buttimore AL, Lynn KL.

Kidney Int. 2000 Jun;57(6):2654-5. No abstract available.

20.

Renal sarcoidosis in Christchurch, New Zealand 1970-1998.

Jose MD, McGregor DO, Lynn KL.

Aust N Z J Med. 1999 Dec;29(6):770-5.

PMID:
10677120
21.

Predicting renal survival in primary focal glomerulosclerosis from the time of presentation.

Chitalia VC, Wells JE, Robson RA, Searle M, Lynn KL.

Kidney Int. 1999 Dec;56(6):2236-42.

22.

Ambulatory blood pressure monitoring in patients receiving long, slow home haemodialysis.

McGregor DO, Buttimore AL, Nicholls MG, Lynn KL.

Nephrol Dial Transplant. 1999 Nov;14(11):2676-9.

PMID:
10534511
23.

Linkage of a gene causing familial focal segmental glomerulosclerosis to chromosome 11 and further evidence of genetic heterogeneity.

Winn MP, Conlon PJ, Lynn KL, Howell DN, Slotterbeck BD, Smith AH, Graham FL, Bembe M, Quarles LD, Pericak-Vance MA, Vance JM.

Genomics. 1999 Jun 1;58(2):113-20.

PMID:
10368108
24.

Hyponatremic-hypertensive syndrome with renal ischemia: an underrecognized disorder.

Agarwal M, Lynn KL, Richards AM, Nicholls MG.

Hypertension. 1999 Apr;33(4):1020-4.

PMID:
10205241
25.

Clinical and genetic heterogeneity in familial focal segmental glomerulosclerosis. International Collaborative Group for the Study of Familial Focal Segmental Glomerulosclerosis.

Winn MP, Conlon PJ, Lynn KL, Howell DN, Gross DA, Rogala AR, Smith AH, Graham FL, Bembe M, Quarles LD, Pericak-Vance MA, Vance JM.

Kidney Int. 1999 Apr;55(4):1241-6.

26.

Haemolytic-uraemic syndrome in a renal transplant recipient treated by conversion to mycophenolate mofetil.

McGregor DO, Robson RA, Lynn KL.

Nephron. 1998 Nov;80(3):365-6. No abstract available.

PMID:
9807054
27.

Intravenous drug use and glomerular deposition of lipid-like material.

Lynn KL, Pickering W, Gardner J, Bailey RR, Robson RA.

Nephron. 1998 Nov;80(3):274-6.

PMID:
9807035
28.

Rapidly progressive IgA nephropathy with anti-myeloperoxidase antibodies responding to immunosuppression.

McGregor D, Lynn KL, Robson R.

Clin Nephrol. 1998 Jul;50(1):64. Review. No abstract available.

PMID:
9710350
29.

Clinical audit of the use of renal biopsy in the management of isolated microscopic hematuria.

McGregor DO, Lynn KL, Bailey RR, Robson RA, Gardner J.

Clin Nephrol. 1998 Jun;49(6):345-8.

PMID:
9696429
30.

Renal dysfunction and the treatment of inflammatory bowel disease (IBD): a case for monitoring.

Howard G, Lynn KL.

Aust N Z J Med. 1998 Jun;28(3):346. No abstract available.

PMID:
9673750
31.

Management guidelines for progressive chronic renal failure. New Zealand Nephrologists Consensus Group.

Simpson IJ, Bailey RR, Robson RA, Price M, Collins JF, Lynn KL.

N Z Med J. 1997 Nov 14;110(1055):421-3. Review.

PMID:
9418827
32.

Comparison of the effects of ouabain and brain natriuretic peptide in saline-loaded sheep.

Pidgeon GB, Richards AM, Nicholls MG, Lewis LK, Yandle TG, Rademaker MT, Charles CJ, Bailey RR, Lynn KL.

Clin Exp Pharmacol Physiol. 1997 Nov;24(11):807-13.

PMID:
9363361
33.

Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.

Bailey RR, Shand BI, Smith AH, Robson RA, Lynn KL.

Clin Nephrol. 1997 Oct;48(4):224-9.

PMID:
9352156
34.

OKT3 for the treatment of steroid-resistant acute renal allograft rejection.

Jogose JT, Bailey RR, Lynn KL, Robson RA, Wells JE.

Nephron. 1997;77(3):298-303.

PMID:
9375823
35.

Living related renal transplantation: the Christchurch experience.

Mantha M, Morton JB, Bailey RR, Robson RA, Lynn KL.

N Z Med J. 1996 Nov 8;109(1033):417-9.

PMID:
8941291
36.

Prospective, randomized, controlled study comparing two dosing regimens of gentamicin/oral ciprofloxacin switch therapy for acute pyelonephritis.

Bailey RR, Begg EJ, Smith AH, Robson RA, Lynn KL, Chambers ST, Barclay ML, Hornibrook J.

Clin Nephrol. 1996 Sep;46(3):183-6.

PMID:
8879853
37.

Audit of the outcome of patients with renal failure presenting to a regional nephrology service.

Lynn KL, Smith AH, Inkster JA, Buttimore AL, Bailey RR, Robson RA.

N Z Med J. 1996 Aug 9;109(1027):295-7.

PMID:
8773673
38.

DMSA renal scans in adults with acute pyelonephritis.

Bailey RR, Lynn KL, Robson RA, Smith AH, Maling TM, Turner JG.

Clin Nephrol. 1996 Aug;46(2):99-104.

PMID:
8869786
39.

Chronic ouabain infusion does not cause hypertension in sheep.

Pidgeon GB, Richards AM, Nicholls MG, Charles CJ, Rademaker MT, Lynn KL, Bailey RR, Lewis LK, Yandle TG.

Am J Physiol. 1996 Mar;270(3 Pt 1):E386-92.

PMID:
8638682
40.

Hyponatraemic hypertensive syndrome in association with bilateral renal artery stenosis.

Wong KM, Lynn KL.

N Z Med J. 1995 Jul 28;108(1004):299-300. No abstract available.

PMID:
7637941
41.

Effect of enalapril on erythrocytosis in hypertensive patients with renal disease.

Shand BI, Bailey RR, Lynn KL, Robson RA.

Blood Press. 1995 Jul;4(4):238-40.

PMID:
7496563
42.

Pregnancy in renal transplant recipients: the Christchurch experience.

Wong KM, Bailey RR, Lynn KL, Robson RA, Abbott GD.

N Z Med J. 1995 May 24;108(1000):190-2.

PMID:
7783987
43.

Effect of enalapril on hemorheology in hypertensive patients with renal disease.

Shand BI, Bailey RR, Lynn KL, Robson RA.

Clin Exp Hypertens. 1995 May;17(4):689-700.

PMID:
7795581
44.

Percutaneous renal biopsy: an audit of a 2 year experience with the Biopty gun.

Voss DM, Lynn KL.

N Z Med J. 1995 Jan 25;108(992):8-10.

PMID:
7862364
45.

Effect of ouabain on pressor responsiveness in normal man.

Pidgeon GB, Richards AM, Nicholls MG, Bailey RR, Lynn KL, Lewis LK, Yandle TG.

Am J Physiol. 1994 Nov;267(5 Pt 1):E642-7.

PMID:
7977713
46.

Altered hemorheology in patients with IgA nephropathy.

Shand BI, Bailey RR, Lynn KL, Robson RA.

Clin Nephrol. 1994 Sep;42(3):204-5. No abstract available.

PMID:
7994942
47.

Long term follow up of patients with IgA nephropathy.

Bailey RR, Lynn KL, Robson RA, Smith AH, Wells JE.

N Z Med J. 1994 Apr 27;107(976):142-4.

PMID:
8164897
48.

End-stage reflux nephropathy.

Bailey RR, Lynn KL, Robson RA.

Ren Fail. 1994;16(1):27-35.

PMID:
8184143
49.

Effect of hemodialysis and recombinant human erythropoietin on determinants of blood viscosity.

Shand BI, Buttimore AL, Lynn KL, Bailey RR, Robson RA.

Ren Fail. 1994;16(3):407-13.

PMID:
8059023
50.

Hemorheology and fistula function in home hemodialysis patients following erythropoietin treatment: a prospective placebo-controlled study.

Shand BI, Buttimore AL, Hurrell MA, Wells JE, Inkster JA, Bailey RR, Robson RA, Lynn KL.

Nephron. 1993;64(1):53-7.

PMID:
7880205

Supplemental Content

Support Center